Sino Biopharmaceutical | 1177 - Equity Capital And Reserves

Stock Price
5.28
Daily Change
-0.02 -0.38%
Monthly
-11.26%
Yearly
26.32%
Q2 Forecast
5.22

Sino Biopharmaceutical reported CNY34B in Equity Capital and Reserves for its fiscal semester ending in June of 2025.





Equity Capital And Reserves Change Date
Akebia Therapeutics USD 27.38M 5.24M Mar/2026
Alaunos Therapeutics USD 1.29M 865K Mar/2026
Avita Medical AUD -16.65M 3.76M Dec/2025
Cspc Pharmaceutical CNY 33.18B 71.46M Dec/2025
Dianthus Therapeutics USD 1.2B 707.91M Mar/2026
Ionis Pharmaceuticals USD 491.41M 2.32M Mar/2026
IQVIA Holdings USD 6.22B 282M Mar/2026
Jiangsu Hengrui CNY 63.63B 2.35B Mar/2026
Moderna USD 7.41B 1.24B Mar/2026
Organon & Co USD 903M 151M Mar/2026
Revvity USD 7.25B 125.54M Dec/2025
Sino Biopharmaceutical CNY 34B 1.48B Jun/2025
Tectonic Therapeutic USD 230.42M 20.91M Mar/2026
Viatris USD 14.66B 53.6M Mar/2026
Xeris Pharmaceuticals USD 13.01M 678K Mar/2026